AddLife AB (publ) (ALIF-B.ST)

SEK 154.0

(-0.9%)

Total Liabilities Summary of AddLife AB (publ)

AddLife AB (publ)'s latest annual total liabilities in 2023 was 7.78 Billion SEK , down -3.72% from previous year.
AddLife AB (publ)'s latest quarterly total liabilities in 2024 Q3 was 7.81 Billion SEK , down -0.91% from previous quarter.
AddLife AB (publ) reported annual total liabilities of 8.08 Billion SEK in 2022, up 28.25% from previous year.
AddLife AB (publ) reported annual total liabilities of 6.3 Billion SEK in 2021, up 179.06% from previous year.
AddLife AB (publ) reported quarterly total liabilities of 7.81 Billion SEK for 2024 Q3, down -0.91% from previous quarter.
AddLife AB (publ) reported quarterly total liabilities of 8.09 Billion SEK for 2024 Q1, up 3.98% from previous quarter.

Annual Total Liabilities Chart of AddLife AB (publ) (2023 - 2012)

Historical Annual Total Liabilities of AddLife AB (publ) (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	7.78 Billion SEK	-3.72%
2022	8.08 Billion SEK	28.25%
2021	6.3 Billion SEK	179.06%
2020	2.25 Billion SEK	25.64%
2019	1.79 Billion SEK	3.58%
2018	1.73 Billion SEK	51.85%
2017	1.14 Billion SEK	27.69%
2016	895.4 Million SEK	-3.77%
2015	930.5 Million SEK	144.87%
2014	380 Million SEK	11.24%
2013	341.6 Million SEK	8.24%
2012	315.6 Million SEK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	7.88 Billion SEK	-2.58%
2024 Q3	7.81 Billion SEK	-0.91%
2024 Q1	8.09 Billion SEK	3.98%
2023 Q2	8.53 Billion SEK	5.77%
2023 Q3	8.13 Billion SEK	-4.76%
2023 FY	7.78 Billion SEK	-3.72%
2023 Q4	7.78 Billion SEK	-4.26%
2023 Q1	8.07 Billion SEK	-0.19%
2022 Q3	8.11 Billion SEK	-0.49%
2022 Q2	8.15 Billion SEK	4.23%
2022 FY	8.08 Billion SEK	28.25%
2022 Q1	7.82 Billion SEK	24.05%
2022 Q4	8.08 Billion SEK	-0.32%
2021 Q3	6.11 Billion SEK	-2.66%
2021 Q1	2.34 Billion SEK	3.84%
2021 Q2	6.27 Billion SEK	167.6%
2021 FY	6.3 Billion SEK	179.06%
2021 Q4	6.3 Billion SEK	3.17%
2020 Q2	1.97 Billion SEK	-6.39%
2020 FY	2.25 Billion SEK	25.64%
2020 Q4	2.25 Billion SEK	22.46%
2020 Q3	1.84 Billion SEK	-6.72%
2020 Q1	2.11 Billion SEK	17.51%
2019 Q3	1.79 Billion SEK	9.67%
2019 Q4	1.79 Billion SEK	0.35%
2019 FY	1.79 Billion SEK	3.58%
2019 Q1	1.36 Billion SEK	-21.2%
2019 Q2	1.63 Billion SEK	19.44%
2018 Q1	1.1 Billion SEK	-3.7%
2018 Q3	1.2 Billion SEK	8.11%
2018 FY	1.73 Billion SEK	51.85%
2018 Q4	1.73 Billion SEK	44.68%
2018 Q2	1.11 Billion SEK	0.82%
2017 Q2	1.1 Billion SEK	-1.87%
2017 Q1	1.12 Billion SEK	30.73%
2017 FY	1.14 Billion SEK	27.69%
2017 Q4	1.14 Billion SEK	-2.37%
2017 Q3	1.17 Billion SEK	6.17%
2016 Q4	859.8 Million SEK	25.15%
2016 Q3	687 Million SEK	-0.07%
2016 Q1	930.5 Million SEK	-17.16%
2016 Q2	687.5 Million SEK	-26.11%
2016 FY	895.4 Million SEK	-3.77%
2015 Q4	1.12 Billion SEK	0.0%
2015 FY	930.5 Million SEK	144.87%
2015 Q1	380 Million SEK	0.0%
2014 FY	380 Million SEK	11.24%
2013 FY	341.6 Million SEK	8.24%
2012 FY	315.6 Million SEK	0.0%

Peer Total Liabilities Comparison of AddLife AB (publ)

Name	Total Liabilities	Total Liabilities Difference
Biotage AB (publ)	1.27 Billion SEK	-511.068%
Bonesupport Holding AB (publ)	143.63 Million SEK	-5319.837%
Doxa AB (publ)	280.8 Million SEK	-2672.436%
Elekta AB (publ)	21.61 Billion SEK	63.99%
iZafe Group AB (publ)	9.26 Million SEK	-83962.196%
Ortivus AB (publ)	55.4 Million SEK	-13952.093%
Ortivus AB (publ)	55.4 Million SEK	-13952.093%
Q-linea AB (publ)	42.34 Million SEK	-18286.868%
S2Medical AB (publ)	19.74 Million SEK	-39318.817%
Synsam AB (publ)	5.52 Billion SEK	-41.007%